#ASCO2017 Histopathologic review of suspected disease progression in patients with recurrent glioblastoma (GBM) receiving nivolumab ± ipilimumab: CheckMate 143. Leia mais »
#ASCO2017 Prognosis of leptomeningeal metastases from melanoma: A case series of 28 patients. Leia mais »
#ASCO2017 Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection, combined with low-dose, targeted radiotherapy (RT)—Phase 1b results. Leia mais »
#ASCO2017 Low grade glioma patients with IDH mutation and 1p19q codeletion: To treat or not to treat? Leia mais »
#ASCO2017 Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma. Leia mais »
#ASCO2017 Randomized, double-blind, phase III trial of a personalized peptide vaccination for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory to temozolomide-based therapy. Leia mais »
#ASCO2017 Association of aggressive resection with survival and progression-free survival in adult low-grade glioma: A systematic review and meta-analysis with numbers needed to treat. Leia mais »
